Literature DB >> 19357549

Normal organ standard uptake values in carbon-11 acetate PET imaging.

Won S Song1, Brett R Nielson, Kevin P Banks, Yong C Bradley.   

Abstract

OBJECTIVE: The goal of this study was to determine normal standard uptake values of carbon-11 (11C) acetate in healthy organs. By accurately determining the range of physiologic activity, abnormal focal or diffuse 11C-acetate activity can be more accurately assessed and thus improve the sensitivity and specificity of this emerging diagnostic PET agent.
METHODS: We reviewed all 55 patients (mean age+/-SD 64.8+/-10.8, age range 35-88 years) who underwent 11C-acetate PET/computed tomography at our institution from 2005 to 2007. Regions of interest were drawn in organs that were devoid of clinical or imaging evidence of disease. The maximum standard uptake value for each region was calculated and analyzed for mean, standard deviation, and 95% confidence intervals.
RESULTS: The results are presented as average maximum standard uptake value+/-1 SD with the pancreas, liver, spleen and salivary glands showing the greatest 11C-acetate avidity. A review of the literature shows our results to be similar to those published earlier.
CONCLUSION: Accurate knowledge of normal biodistribution and standardized uptake values will provide the foundation for assessing focal or diffuse organ disease while using this PET agent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19357549     DOI: 10.1097/MNM.0b013e32832aa7ce

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  8 in total

1.  Novel positron emission tomography tracer distinguishes normal from cancerous cells.

Authors:  Muhammad Saeed; David Sheff; Amnon Kohen
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

2.  Targeting the de novo biosynthesis of thymidylate for the development of a PET probe for pancreatic cancer imaging.

Authors:  Thushani D Nilaweera; Muhammad Saeed; Amnon Kohen
Journal:  Biochemistry       Date:  2015-01-27       Impact factor: 3.162

3.  PET/CT in prostate cancer: non-choline radiopharmaceuticals.

Authors:  P Castellucci; H Jadvar
Journal:  Q J Nucl Med Mol Imaging       Date:  2012-08       Impact factor: 2.346

4.  Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation.

Authors:  Jae Seon Eo; Jin Chul Paeng; Dong Soo Lee
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

5.  68Ga-PSMA PET/CT Versus 18F-FDG PET/CT for Imaging of Hepatocellular Carcinoma

Authors:  Cihan Gündoğan; Nurhan Ergül; Mehmet Semih Çakır; Özgür Kılıçkesmez; Rıza Umar Gürsu; Tamer Aksoy; Tevfik Fikret Çermik
Journal:  Mol Imaging Radionucl Ther       Date:  2021-06-03

Review 6.  Gut Biofactory-Neurocompetent Metabolites within the Gastrointestinal Tract. A Scoping Review.

Authors:  Karolina Skonieczna-Żydecka; Karolina Jakubczyk; Dominika Maciejewska-Markiewicz; Katarzyna Janda; Karolina Kaźmierczak-Siedlecka; Mariusz Kaczmarczyk; Igor Łoniewski; Wojciech Marlicz
Journal:  Nutrients       Date:  2020-11-01       Impact factor: 5.717

Review 7.  Modulation of Adipocyte Metabolism by Microbial Short-Chain Fatty Acids.

Authors:  Karolline S May; Laura J den Hartigh
Journal:  Nutrients       Date:  2021-10-19       Impact factor: 5.717

8.  Systemic Concentrations of Short Chain Fatty Acids Are Elevated in Salmonellosis and Exacerbation of Familial Mediterranean Fever.

Authors:  Zhanna A Ktsoyan; Mkhitar S Mkrtchyan; Magdalina K Zakharyan; Armine A Mnatsakanyan; Karine A Arakelova; Zaruhi U Gevorgyan; Anahit M Sedrakyan; Alvard I Hovhannisyan; Arsen A Arakelyan; Rustam I Aminov
Journal:  Front Microbiol       Date:  2016-05-24       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.